ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EVOTF Evotec SE (PK)

9.34
0.00 (0.00%)
11 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Evotec SE (PK) USOTC:EVOTF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.34 8.80 9.70 0.00 22:00:01

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

20/06/2023 6:24pm

Edgar (US Regulatory)


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE MONTH OF JUNE 2023

 

COMMISSION FILE NUMBER 001-34041

 

Evotec SE

(Translation of registrant’s name into English)

 

Essener Bogen 7

22419 Hamburg

Germany

Tel: +49 40 560810

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F: Form 20‑F ☒   Form 40‑F ☐

 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7): ☐

 

 

 

 

DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K

 

Explanatory Note

 

On June 20, 2023, Evotec SE (the “Company”) announced that its shareholders approved all proposals the Company’s Management put to vote at the Company’s virtual Annual General Meeting 2023 with the required majority. The press release is attached hereto as Exhibit 99.1. The voting results are attached hereto as Exhibit 99.2.

 

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Evotec SE

       
By: /s/ Laetitia Rouxel

 

 

Name: Laetitia Rouxel  
    Title: Chief Financial Officer  

 Date: 20th June 2023

 

 

3

 

 

EXHIBIT INDEX

 

Exhibit

 

Description of Exhibit

99.1

 

Evotec SE Annual General Meeting 2023 approves all proposed agenda items

99.2

 

Annual General Meeting 2023 Voting Results

 

 

4

 

 

 

1 Year Evotec (PK) Chart

1 Year Evotec (PK) Chart

1 Month Evotec (PK) Chart

1 Month Evotec (PK) Chart

Your Recent History

Delayed Upgrade Clock